Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


All Change For BIA Board

This article was originally published in Scrip

Executive Summary

The UK BioIndustry Association (BIA) has named Dr. Jane Osbourn – current vice-president of research and development at MedImmune LLC (an AstraZeneca plc company) – its new chair, effective January 2016. Osbourn has over 25 years of experience in the life science sector, initially as an academic before moving into biotech with Cambridge Antibody Technology in 1993. Osbourn received her Ph.D. from the John Innes Centre for Plant Science Research in Norwich. She succeeds Dr. Edward Hodgkin, CEO of Autolus, who is standing down as chair of the board but will remain a director.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts